A clinicopathological analysis of 26 patients with infection-associated haemophagocytic lymphohistiocytosis and the importance of bone marrow phagocytosis for the early initiation of immunomodulatory treatment

Postgraduate Medical Journal

Volumn 89, Issue 1050, 2013, Pages 185-192

  Nair, Velu ^a   Das, Satyaranjan ^b   Sharma, Ajay ^b   Sharma, Sanjeevan ^b   Sharma, Prafull ^a   Ray, Sougat ^a   Bhattacharya, Shilajit ^b  

^a ARMED FORCES MEDICAL COLLEGE   (India)

^b ARMY HOSPITAL RESEARCH AND REFERRAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPHOTERICIN; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ARTEMISININ; ARTESUNATE; CASPOFUNGIN; CEFTRIAXONE; CEPHALOSPORIN; CYCLOSPORIN A; DEXAMETHASONE; DOXYCYCLINE; ETOPOSIDE; FERRITIN; FIBRINOGEN; GENTAMICIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN M; LACTATE DEHYDROGENASE; LAMIVUDINE; METHYLPREDNISOLONE; STEROID; TUBERCULOSTATIC AGENT; VORICONAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASPERGILLOSIS; ASSISTED VENTILATION; BONE MARROW BIOPSY; CANDIDEMIA; CHILD; CLINICAL ARTICLE; DEATH; DENGUE; EPSTEIN BARR VIRUS INFECTION; ERYTHROPHAGOCYTOSIS; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HEMOPHAGOCYTIC SYNDROME; HUMAN; HUMAN TISSUE; INFECTION ASSOCIATED HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; KIKUCHI DISEASE; LEISHMANIASIS; MALARIA; MALE; PANCYTOPENIA; PHAGOCYTOSIS; POLYMERASE CHAIN REACTION; SCHOOL CHILD; SEPSIS; THROMBOCYTE TRANSFUSION; TUBERCULOSIS; TYPHOID FEVER; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BONE MARROW; CHILD; COST-BENEFIT ANALYSIS; DELAYED DIAGNOSIS; DEVELOPING COUNTRIES; DISEASE PROGRESSION; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; FERRITINS; FEVER; HEPATOMEGALY; HUMANS; IMMUNOMODULATION; INDIA; L-LACTATE DEHYDROGENASE; LIVER FUNCTION TESTS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; MIDDLE AGED; PHAGOCYTOSIS; PLATELET COUNT; RISK FACTORS; SPLENOMEGALY; VIRUS DISEASES;

EID: 84875112351     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/postgradmedj-2012-130955     Document Type: Article

References (22)

1. Scott R, Robb-Smith AH. Histiocytic medullary reticulosis. Lancet 1939;2:194-8.
2. Rouphael NG, Talati NJ, Vaughan C, et al. Infections associated with haemophagocytic syndrome. Lancet Infect Dis 2007;7:814-22.
3. Risdall RJ, McKenna RW, Nesbit ME, et al. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 1979;44:993-1002.
4. Henter JL. Diagnosis guidelines for hemophagocytic lymphohistiocytosis. Semin Oncol 1991;18:29-33.
5. Favara BE. Contemporary classification of histiocytic disorders. Med Pediatr Oncol 1997;29:157-66.
6. Ramchandran B, Balasubramaniam S, Abhishek N, et al. Profile of hemophagocytic lymphohystiocytosis in children in a tertiary care hospital in India. Indian Pediatr 2011;48:31-5.
7. Arico M, Danesino C, Pende D, et al. Pathogenesis of haemophagocytic lymphohistiocytosis. Br J Haematol 2001;114:761-9.
8. Chen RL, Lin KH, Lin DT, et al. Immunomodulation treatment for childhood virus associated lymphophagocytic lymphohystiocytosis. Br J Haematol 1995;89:282-90.
9. Zhang Y, Nagata H, Ikeuchi T, et al. Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions. Br J Haematol 2003;121:805-14.
10. Singh ZN, Rakheja D, Yadav TP, et al. Infection-associated haemophagocytosis: the tropical spectrum. Clin Lab Haematol 2005;27:312-15.
11. Henter JI, Horne A, Aricó M, et al. HLH-2004: diagnostic and therapeutic guidelines for haemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48:124-31.
12. Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 1991;18:29-33.
13. Chen RL, Su IJ, Lin KH, et al. Fulminant childhood hemophagocytic syndrome mimicking histiocytic medullary reticulosis. An atypical form of EB virus infection. Am J Clin Patho 1991;96:171-6.
14. Filipovich AH. Life-threatening hemophagocytic syndromes: current outcomes with hematopoietic stem cell transplantation. Pediatr Transplant 2005;9:87-91.
15. Dhote R, Simon J, Papo T, et al. Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis Rheum 2003;49:633-9.
16. Numata K, Tsutsumi H, Wakai S, et al. A child case of haemophagocytic syndrome associated with cryptococcal meningoencephalitis. J Infect 1998;36:118-19.80.
17. Koduri PR, Chundi V, DeMarais P, et al. Reactive hemophagocytic syndrome: a new presentation of disseminated histoplasmosis in patients with AIDS. Clin Infect Dis 1995;21:1463-65.
18. Filipovich AH. Hemophagocytic Lymphohystiocytosis (HLH) and related disorders. Hematology 2009;1:127-31.
19. Rhoades CJ, Williams MA, Kelsey SM, et al. Monocyte-macrophage system as targets for immunomodulation by intravenous immunoglobulin. Blood Rev 2000;14:14-30.
20. Samuelsson A, Towers TL, Ravetch JV. Anti-inflammatory activity of IVIg mediated through the inhibitory Fc receptor. Science 2001;291:484-6.
21. Quesnel B, Catteau B, Aznar V, et al. Successful treatment of juvenile rheumatoid arthritis associated haemophagocytic syndrome by cyclosporin A with transient exacerbation by conventional-dose G-CSF. Br J Haematol 1997;97:508-10.
22. Wang S, Degar BA, Zieske A, et al. Hemophagocytosis exacerbated by G-CSF/GM-CSF treatment in a patient with myelodysplasia. Am J Hematol 2004;77:391-6.